Incretin and insulin signaling as novel therapeutic targets for Alzheimer's and Parkinson's disease
J Nowell, E Blunt, P Edison - Molecular Psychiatry, 2023 - nature.com
Despite an ever-growing prevalence and increasing economic burden of Alzheimer's
disease (AD) and Parkinson's disease (PD), recent advances in drug development have …
disease (AD) and Parkinson's disease (PD), recent advances in drug development have …
Apoptosis in Alzheimer's disease: insight into the signaling pathways and therapeutic avenues
S Kumari, R Dhapola, DHK Reddy - Apoptosis, 2023 - Springer
Alzheimer's disease (AD) is characterized by the accumulation of hyperphosphorylated tau
and amyloid-β (Aβ) protein resulting in synaptic loss and apoptosis. Aβ and tau deposition …
and amyloid-β (Aβ) protein resulting in synaptic loss and apoptosis. Aβ and tau deposition …
[HTML][HTML] The neuroprotective effects of glucagon-like peptide 1 in Alzheimer's and Parkinson's disease: An in-depth review
N Reich, C Hölscher - Frontiers in neuroscience, 2022 - frontiersin.org
Currently, there is no disease-modifying treatment available for Alzheimer's and Parkinson's
disease (AD and PD) and that includes the highly controversial approval of the Aβ-targeting …
disease (AD and PD) and that includes the highly controversial approval of the Aβ-targeting …
Insulin resistance, autophagy and apoptosis in patients with polycystic ovary syndrome: Association with PI3K signaling pathway
C Tong, Y Wu, L Zhang, Y Yu - Frontiers in Endocrinology, 2022 - frontiersin.org
Polycystic ovary syndrome (PCOS) is a disease in which endocrine metabolic abnormalities
coexist with reproductive system abnormalities, with the main clinical manifestations …
coexist with reproductive system abnormalities, with the main clinical manifestations …
[HTML][HTML] Effects of ketogenic diet on neuroinflammation in neurodegenerative diseases
Z Jiang, X Yin, M Wang, T Chen, Y Wang, Z Gao… - Aging and …, 2022 - ncbi.nlm.nih.gov
The ketogenic diet (KD) is a low-carbohydrate, high-fat and adequate-protein diet. As a diet
mimicking fasting, it triggers the production of ketone bodies (KBs) and brings the body into …
mimicking fasting, it triggers the production of ketone bodies (KBs) and brings the body into …
[HTML][HTML] Environmental endocrine disruptor Bisphenol A induces metabolic derailment and obesity via upregulating IL-17A in adipocytes
X Hong, Y Zhou, Z Zhu, Y Li, Z Li, Y Zhang, X Hu… - Environment …, 2023 - Elsevier
Abstract Background Bisphenol A (BPA), a ubiquitous environmental endocrine disruptor,
has been extensively demonstrated to be associated with metabolic disorders, including …
has been extensively demonstrated to be associated with metabolic disorders, including …
Impairment of insulin signaling pathway PI3K/Akt/mTOR and insulin resistance induced AGEs on diabetes mellitus and neurodegenerative diseases: a perspective …
K Ramasubbu, V Devi Rajeswari - Molecular and Cellular Biochemistry, 2023 - Springer
Insulin resistance is common in type 2 diabetes mellitus (T2DM), neurodegenerative
diseases, cardiovascular diseases, kidney diseases, and polycystic ovary syndrome …
diseases, cardiovascular diseases, kidney diseases, and polycystic ovary syndrome …
The neuroprotective effects of intermittent fasting on brain aging and neurodegenerative diseases via regulating mitochondrial function
Y Zhao, M Jia, W Chen, Z Liu - Free Radical Biology and Medicine, 2022 - Elsevier
Intermittent fasting (IF) has been studied for its effects on lifespan and the prevention or
delay of age-related diseases upon the regulation of metabolic pathways. Mitochondria …
delay of age-related diseases upon the regulation of metabolic pathways. Mitochondria …
Proprotein convertase subtilisin/kexin type 9 (PCSK9) in the central nervous system
AS Bell, J Wagner, DB Rosoff, FW Lohoff - Neuroscience & Biobehavioral …, 2023 - Elsevier
The gene encoding proprotein convertase subtilisin/kexin type 9 (PCSK9) and its protein
product have been widely studied for their role in cholesterol and lipid metabolism. PCSK9 …
product have been widely studied for their role in cholesterol and lipid metabolism. PCSK9 …
Incretin-based drugs as potential therapy for neurodegenerative diseases: current status and perspectives
Alzheimer's disease (AD) and Parkinson's disease (PD) are the most frequent
neurodegenerative disorders. Despite their pathophysiological and clinical differences, they …
neurodegenerative disorders. Despite their pathophysiological and clinical differences, they …